skip navigation

PUBLICATIONS

Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.

 

NCJ Number: 201817 Find in a Library
Title: PCP: The Threat Remains
Corporate Author: Drug Enforcement Admin
US Dept of Justice
United States of America
Date Published: May 2003
Page Count: 8
Sponsoring Agency: Drug Enforcement Admin
Springfield, VA 22152
NCJRS Photocopy Services
Rockville, MD 20849-6000
Sale Source: Drug Enforcement Admin
US Dept of Justice
8701 Morrissette Drive
Springfield, VA 22152
United States of America

NCJRS Photocopy Services
Box 6000
Rockville, MD 20849-6000
United States of America
Document: PDF
Type: Issue Overview
Format: Document (Online)
Language: English
Country: United States of America
Annotation: After reviewing the historical background of phencyclidine (PCP), this report discusses its forms, effects, and methods of administration; evolution of abuse; abuse indicators; manufacture; chemical sources; distribution; transportation and seizures; and prices.
Abstract: In 1963 PCP was patented and marketed in the United States as a surgical analgesic and anesthetic under the trade name Sernyl; however, due to adverse collateral symptoms, Sernyl was withdrawn from the market in 1965. In 1967 the first reported illicit use of PCP occurred in the Haight-Ashbury District in San Francisco. In January 1978, PCP was transferred from Schedule III to Schedule II under the Controlled Substances Act of 1970. PCP has been described as one of the most dangerous of all synthetic hallucinogens. Abusers tend to exhibit hostile behavior that manifests itself in extremely violent episodes. PCP is available in powder, crystal, tablet, capsule, and liquid forms, and it can be abused by snorting, smoking, or swallowing the drug. Smoking is the most common method of abuse. PCP intoxication may last between 4 and 8 hours when consumed in a recreational dose, although some users report subjective effects for between 24 and 48 hours. The Los Angeles area is the primary manufacturing source for the majority of PCP found in the United States. It is relatively easy to manufacture and is commonly produced in liquid form. Illicit organizations that produce and distribute PCP operate mainly in Los Angeles and, to as lesser extent, in Houston. The recent emergence of large PCP laboratories in other locations, however, such as Indiana and Maryland, are cause for concern. According to the Drug Abuse Warning Network, the number of PCP-related emergency room visits has increased 78 percent from 1998 to 2001 (from 3,436 to 6,102 visits). PCP-laced cigarettes and joints reportedly sell for between $5 and $30 each, and PCP is available in tablet form at from $20 to $30, although availability in this form is limited.
Main Term(s): Drug information
Index Term(s): Drug effects; Drug law enforcement; Drug laws; Drug manufacturing; Drug smuggling; PCP (phencyclidine hydrochloride)
Note: Drug Intelligence Brief, May 2003; downloaded August 28, 2003.
To cite this abstract, use the following link:
http://www.ncjrs.gov/App/publications/abstract.aspx?ID=201817

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.